ANG Lifesciences India Ltd - Outcome of Board Meeting

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors of the Company in its Meeting held on November 21, 2017 has considered and approved the Un-audited Financial Results for the Half Year ended September 30, 2017 alongwith Statement of Assets and Liabilities as at September 30, 2017 and the Limited Review Report of the Auditors thereon